Leeward Investments LLC MA Has $9.90 Million Stock Position in Silicon Laboratories Inc. (NASDAQ:SLAB)

Leeward Investments LLC MA raised its holdings in Silicon Laboratories Inc. (NASDAQ:SLAB) by 5.6% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 89,467 shares of the semiconductor company’s stock after buying an additional 4,762 shares during the period. Leeward Investments LLC MA’s holdings in Silicon Laboratories were worth $9,898,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. GAMMA Investing LLC acquired a new position in Silicon Laboratories in the 4th quarter valued at $36,000. Gladius Capital Management LP raised its stake in Silicon Laboratories by 328.7% in the 4th quarter. Gladius Capital Management LP now owns 373 shares of the semiconductor company’s stock worth $49,000 after purchasing an additional 286 shares in the last quarter. CWM LLC boosted its holdings in Silicon Laboratories by 78.1% in the 4th quarter. CWM LLC now owns 374 shares of the semiconductor company’s stock valued at $49,000 after purchasing an additional 164 shares during the period. Fidelis Capital Partners LLC acquired a new position in shares of Silicon Laboratories during the 1st quarter worth approximately $55,000. Finally, Mather Group LLC. acquired a new position in shares of Silicon Laboratories during the 1st quarter worth approximately $63,000.

Silicon Laboratories Trading Down 0.4 %

NASDAQ SLAB traded down $0.42 during trading hours on Monday, hitting $103.88. The company’s stock had a trading volume of 8,252 shares, compared to its average volume of 310,786. The company has a market capitalization of $3.35 billion, a PE ratio of -31.51 and a beta of 1.19. Silicon Laboratories Inc. has a 52 week low of $74.56 and a 52 week high of $154.91. The company’s 50-day simple moving average is $112.45 and its two-hundred day simple moving average is $124.40.

Silicon Laboratories (NASDAQ:SLAB) last issued its quarterly earnings results on Wednesday, July 24th. The semiconductor company reported ($0.56) EPS for the quarter, beating analysts’ consensus estimates of ($0.64) by $0.08. The company had revenue of $145.40 million during the quarter, compared to the consensus estimate of $140.18 million. Silicon Laboratories had a negative return on equity of 9.13% and a negative net margin of 36.53%. During the same period last year, the business posted $0.59 earnings per share. Silicon Laboratories’s revenue was down 40.6% on a year-over-year basis. Research analysts anticipate that Silicon Laboratories Inc. will post -3.4 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Robert Matthew Johnson sold 7,230 shares of the firm’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $123.80, for a total value of $895,074.00. Following the completion of the transaction, the chief executive officer now directly owns 47,910 shares of the company’s stock, valued at approximately $5,931,258. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.72% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on SLAB. Benchmark reissued a “hold” rating on shares of Silicon Laboratories in a report on Thursday, April 25th. Barclays dropped their target price on shares of Silicon Laboratories from $140.00 to $120.00 and set an “equal weight” rating for the company in a research report on Thursday, April 25th. JPMorgan Chase & Co. reduced their price target on shares of Silicon Laboratories from $165.00 to $150.00 and set an “overweight” rating on the stock in a research report on Thursday, April 25th. TD Cowen lowered their price objective on shares of Silicon Laboratories from $155.00 to $145.00 and set a “buy” rating for the company in a research report on Thursday, April 25th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $150.00 target price on shares of Silicon Laboratories in a report on Thursday, July 25th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, Silicon Laboratories currently has a consensus rating of “Hold” and a consensus target price of $135.00.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.